Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

NCT06116916 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema (DME)

Interventions

DRUG: KHK4951
DRUG: Aflibercept Injection

Sponsor

Kyowa Kirin Co., Ltd.